Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery.

Magnetic targeting is useful for intravascular or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such in vivo applications, the magnetic drug carrier must be biocompatible and nontoxic. In this work, we investigated the toxic properties of magnetic nanoparticles coated with polyethylenoxide (PEO) triblock copolymers. Such coatings prevent the aggregation of magnetic nanoparticles and guarantee consistent magnetic and nonmagnetic flow properties. It was found that the PEO tail block length inversely correlates with toxicity. The nanoparticles with the shortest 0.75 kDa PEO tails were the most toxic, while particles coated with the 15 kDa PEO tail block copolymers were the least toxic. Toxicity responses of the tested prostate cancer cell lines (PC3 and C4-2), human umbilical vein endothelial cells (HUVECs), and human retinal pigment epithelial cells (HRPEs) were similar. Furthermore, all cell types took up the coated magnetic nanoparticles. It is concluded that magnetite nanoparticles coated with triblock copolymers containing PEO tail lengths of above 2 kDa are biocompatible and appropriate for in vivo application.

[1]  U. Häfeli,et al.  The biocompatibility and toxicity of magnetic particles , 2007 .

[2]  R. Weissleder,et al.  Cell-specific targeting of nanoparticles by multivalent attachment of small molecules , 2005, Nature Biotechnology.

[3]  Mingyuan Gao,et al.  Preparation of magnetite nanocrystals with surface reactive moieties by one-pot reaction. , 2007, Journal of colloid and interface science.

[4]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[5]  D. Piwnica-Worms,et al.  Permeation Peptide Conjugates for In Vivo Molecular Imaging Applications , 2006, Molecular imaging.

[6]  George T. Gillies,et al.  Magnetic guidance of ferrofluidic nanoparticles in an in vitro model of intraocular retinal repair , 2003 .

[7]  G. Frija,et al.  MR lymphography: evidence of extravasation of superparamagnetic nanoparticles into the lymph. , 1998, Academic radiology.

[8]  Michael D. Kaminski,et al.  Preparation and characterization of biodegradable magnetic carriers by single emulsion-solvent evaporation , 2007 .

[9]  Hanwen Sun,et al.  188Re-labeled MPEG-modified superparamagnetic nanogels: preparation and targeting application in rabbits , 2008, Biomedical microdevices.

[10]  R Weissleder,et al.  Size optimization of synthetic graft copolymers for in vivo angiogenesis imaging. , 2001, Bioconjugate chemistry.

[11]  D. Montgomery,et al.  A new magnetic technique for the treatment of giant retinal tears. , 1978, American journal of ophthalmology.

[12]  J. Rosenecker,et al.  siRNA delivery by magnetofection. , 2008, Current opinion in molecular therapeutics.

[13]  Richard O. Claus,et al.  Synthesis, characterization and targeting of biodegradable magnetic nanocomposite particles by external magnetic fields , 2005 .

[14]  Bobbi K Lewis,et al.  A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging , 2005, NMR in biomedicine.

[15]  J. H. Kim,et al.  Effects of surfactant on properties of magnetic fluids for biomedical application , 2004 .

[16]  J. Frank,et al.  Cellular magnetic resonance imaging: current status and future prospects , 2006, Expert review of medical devices.

[17]  N. Buske,et al.  Selective reduction of the interaction of magnetic nanoparticles with leukocytes and tumor cells by human plasma , 2005 .

[18]  Rajiv Gulati,et al.  Magnetically targeted endothelial cell localization in stented vessels. , 2006, Journal of the American College of Cardiology.

[19]  Taeghwan Hyeon,et al.  Chemical Synthesis of Magnetic Nanoparticles , 2003 .

[20]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[21]  Raoul Kopelman,et al.  Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors , 2006, Clinical Cancer Research.

[22]  D. Kraitchman,et al.  Stem cell therapy: MRI guidance and monitoring , 2008, Journal of magnetic resonance imaging : JMRI.

[23]  Klaas Nicolay,et al.  Magnetic and fluorescent nanoparticles for multimodality imaging. , 2007, Nanomedicine.

[24]  Rong Zhou,et al.  Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. , 2004, Academic radiology.

[25]  J. Rosenecker,et al.  Gene delivery to respiratory epithelial cells by magnetofection , 2004, The journal of gene medicine.

[26]  Carl K. Hoh,et al.  Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy , 1999 .

[27]  R. Ivkov,et al.  Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy , 2005, Clinical Cancer Research.

[28]  C. Compton,et al.  Ferrite particles: a new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatotoxicity after intravenous administration. , 1987, The Journal of laboratory and clinical medicine.

[29]  T. Kissel,et al.  Biocompatibility testing of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture models. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Tae-Jong Yoon,et al.  Toxicity and tissue distribution of magnetic nanoparticles in mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[31]  U. Häfeli,et al.  Preparation of biodegradable magnetic microspheres with poly(lactic acid)-coated magnetite , 2009 .

[32]  L. Trahms,et al.  Drug loaded magnetic nanoparticles for cancer therapy , 2006 .

[33]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.

[34]  Richey M. Davis,et al.  Aqueous dispersions of magnetite nanoparticles complexed with copolyether dispersants: experiments and theory. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[35]  C. Driscoll,et al.  Magnetic targeting of microspheres in blood flow. , 1984, Microvascular research.

[36]  M. Saunders,et al.  Magnetite Nanoparticle Dispersions Stabilized with Triblock Copolymers , 2003 .

[37]  U. Häfeli,et al.  In vitro and in vivo toxicity of magnetic microspheres , 1999 .

[38]  A. Amirfazli,et al.  Factors affecting magnetic retention of particles in the upper airways: an in vitro and ex vivo study. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[39]  G. Morana,et al.  Contrast agents for hepatic MRI , 2007, Cancer imaging : the official publication of the International Cancer Imaging Society.

[40]  Ralph Weissleder,et al.  Nanoparticle imaging of integrins on tumor cells. , 2006, Neoplasia.

[41]  Miqin Zhang,et al.  Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[42]  J. Gallo,et al.  Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres. , 1998, Journal of drug targeting.

[43]  C. Rinaldi,et al.  Colloidal dispersions of monodisperse magnetite nanoparticles modified with poly(ethylene glycol). , 2009, Journal of colloid and interface science.

[44]  P. Meyers,et al.  EXPERIMENTAL APPROACH IN THE USE AND MAGNETIC CONTROL OF METALLIC IRON PARTICLES IN THE LYMPHATIC AND VASCULAR SYSTEM OF DOGS AS A CONTRAST AND ISOTOPIC AGENT. , 1963, The American journal of roentgenology, radium therapy, and nuclear medicine.

[45]  R B Greenwald,et al.  PEG drugs: an overview. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Christian Plank,et al.  Generation of magnetic nonviral gene transfer agents and magnetofection in vitro , 2007, Nature Protocols.

[47]  Y. Kaneda,et al.  Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. , 2005, Biochemical and biophysical research communications.

[48]  R. Woodward,et al.  Field-induced motion of ferrofluids through immiscible viscous media: Testbed for restorative treatment of retinal detachment , 2007 .

[49]  R Weissleder,et al.  Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. , 2001, Journal of immunological methods.

[50]  Diandra L. Leslie-Pelecky,et al.  Magnetic studies of iron oxide nanoparticles coated with oleic acid and Pluronic® block copolymer , 2005 .

[51]  Joseph Rosenecker,et al.  Enhancing and targeting nucleic acid delivery by magnetic force , 2003, Expert opinion on biological therapy.

[52]  K. Sugibayashi,et al.  Biomedical applications of magnetic fluids. i. Magnetic guidance of ferro-colloid-entrapped albumin microsphere for site specific drug delivery in vivo. , 1980, Journal of pharmacobio-dynamics.

[53]  P. Couvreur,et al.  Surface-engineered nanoparticles for multiple ligand coupling. , 2003, Biomaterials.

[54]  Bernhard Gleich,et al.  Targeted delivery of magnetic aerosol droplets to the lung , 2007, Nature Nanotechnology.

[55]  C James Kirkpatrick,et al.  Effects of nano-scaled particles on endothelial cell function in vitro: Studies on viability, proliferation and inflammation , 2004, Journal of materials science. Materials in medicine.